Effect of GLP-1 Receptor Activation on Offspring Kidney Health in a Rat Model of Maternal Obesity

[1]  J. Holst,et al.  Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow. , 2015, American journal of physiology. Renal physiology.

[2]  W. Hall,et al.  Risk for chronic kidney disease increases with obesity: Health Survey for England 2010 , 2015, Public Health Nutrition.

[3]  M. Wong,et al.  A Cationic-Independent Mannose 6-Phosphate Receptor Inhibitor (PXS64) Ameliorates Kidney Fibrosis by Inhibiting Activation of Transforming Growth Factor-β1 , 2015, PloS one.

[4]  J. Proietto,et al.  The effect of rate of weight loss on long-term weight management: a randomised controlled trial. , 2014, The lancet. Diabetes & endocrinology.

[5]  Xiao-ming Meng,et al.  Inflammatory processes in renal fibrosis , 2014, Nature Reviews Nephrology.

[6]  J. Skov,et al.  Effects of GLP-1 in the Kidney , 2014, Reviews in Endocrine and Metabolic Disorders.

[7]  Myung‐Sook Choi,et al.  Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease , 2014, International journal of molecular sciences.

[8]  Yuichiro Yamada,et al.  The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential. , 2014, Kidney international.

[9]  S. Saad,et al.  Exendin-4 is effective against metabolic disorders induced by intrauterine and postnatal overnutrition in rodents , 2014, Diabetologia.

[10]  Michael E. Hall,et al.  Obesity, hypertension, and chronic kidney disease , 2014, International journal of nephrology and renovascular disease.

[11]  D. Koya,et al.  The biological consequence of obesity on the kidney. , 2013, Nephrology, Dialysis and Transplantation.

[12]  W. McClellan,et al.  A public health perspective on CKD and obesity. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  G. Mcneill,et al.  Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: follow-up of 1 323 275 person years , 2013, BMJ.

[14]  R. Nelson,et al.  Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy , 2012, Kidney international.

[15]  E. Ozbek.  Induction of Oxidative Stress in Kidney , 2012, International journal of nephrology.

[16]  R. Seeley,et al.  High-fat-diet-induced obesity causes an inflammatory and tumor-promoting microenvironment in the rat kidney , 2012, Disease Models & Mechanisms.

[17]  A. Elmarakby,et al.  Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. , 2012, Cardiovascular therapeutics.

[18]  D. Sloboda,et al.  Maternal Obesity and Developmental Programming of Metabolic Disorders in Offspring: Evidence from Animal Models , 2011, Experimental diabetes research.

[19]  D. Dabelea,et al.  Maternal Environment and the Transgenerational Cycle of Obesity and Diabetes , 2011, Diabetes.

[20]  S. Ozanne,et al.  Developmental Programming in Response to Maternal Overnutrition , 2011, Front. Gene..

[21]  R. Kalluri,et al.  Mechanistic connection between inflammation and fibrosis. , 2010, Kidney international. Supplement.

[22]  P. Catalano.  Obesity, insulin resistance, and pregnancy outcome. , 2010, Reproduction.

[23]  Luca Scalfi,et al.  Excess Body Weight and Incidence of Stroke: Meta-Analysis of Prospective Studies With 2 Million Participants , 2010, Stroke.

[24]  J. Duffield.  Macrophages and immunologic inflammation of the kidney. , 2010, Seminars in nephrology.

[25]  L. Poston,et al.  Maternal Diet-Induced Obesity Alters Mitochondrial Activity and Redox Status in Mouse Oocytes and Zygotes , 2010, PloS one.

[26]  R. D. de Haan,et al.  Patch: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial , 2010, BMC neurology.

[27]  Jennifer S. Mindell,et al.  Health Survey for England 2008 , 2009 .

[28]  A. Kribben,et al.  Serum cystatin C in mouse models: a reliable and precise marker for renal function and superior to serum creatinine. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  M. Honda,et al.  Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. , 2008, Metabolism: clinical and experimental.

[30]  F. Hu,et al.  Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. , 2007, Archives of internal medicine.

[31]  T. Jiang,et al.  Diet-induced Obesity in C57BL/6J Mice Causes Increased Renal Lipid Accumulation and Glomerulosclerosis via a Sterol Regulatory Element-binding Protein-1c-dependent Pathway* , 2005, Journal of Biological Chemistry.

[32]  A. Eddy.  Molecular insights into renal interstitial fibrosis. , 1996, Journal of the American Society of Nephrology : JASN.

[33]  S. Silbiger,et al.  The impact of gender on the progression of chronic renal disease. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  Aline Haas de Mello,et al.  Mitochondrial dysfunction in obesity , 2018, Life sciences.

[35]  K. Sharma,et al.  Obesity related kidney disease. , 2011, Current Diabetes Reviews.